Clinical Investigation

Kidney International (1991) 40, 1134–1140; doi:10.1038/ki.1991.325

Renal functional reserve: Its significance in normal and salt depletion conditions

Bruno Memoli1, Carmelo Libetta1, Massimo Sabbatini1, Giuseppe Conte1, Domenico Russo1, Umberto Giani1, Domenico Capone1 and Vittorio E Andreucci1

1Department of Nephrology, Department of Communication Sciences and Institute of Pharmacology, II Faculty of Medicine, and Department of Nephrology, I Faculty of Medicine, University of Naples, Naples, Italy

Correspondence: Bruno Memoli MD, Department of Nephrology, II Faculty of Medicine, University of Naples, Via S. Pansini 5, Edificio 5, 80131 Napoli, Italy.

Received 6 March 1991; Revised 15 July 1991; Accepted 16 July 1991.

Top

Abstract

Renal functional reserve: Its significance in normal and salt depletion conditions. The aim of this study was the evaluation, in healthy subjects, of the renal functional reserve (RFR), that is, the GFR increase induced by a combined infusion of amino acids (AA) and dopamine (D), in conditions of extracellular volume depletion caused by diuretic administration. In particular, this study was undertaken: a) to evaluate whether and to which extent, AA + D can reverse the functional GFR impairment induced by salt depletion, without volume restoration; b) to study whether any relationship may be found between the GFR in normal condition (the so-called "resting" GFR), and/or the renal functional reserve and the GFR impairment induced by salt depletion, in order to understand the role of both "resting" GFR and RFR in the degree of renal dysfunction induced by salt depletion. In control conditions the i.v. infusion of AA + D significantly increased RPF (+ 41% vs. baseline period) with a mean absolute increase of 211 ml/min. A similar pattern was observed in GFR behavior (+ 31.5% with 34 ml/min of mean absolute increase). A significant inverse exponential relationship was observed between GFR before A A + D i.v. infusion ("resting" GFR) and renal functional reserve (P < 0.05), suggesting that, in normal conditions, these inversely related parameters may widely vary according to the tone of the glomerular arterioles. Following salt depletion, we observed a variable degree of GFR impairment. Both GFR and RPF were significantly decreased (-25.9%, P < 0.05 and -29%, P < 0.05, respectively). The GFR impairment was mainly caused by a significant increase in tone of glomerular arterioles presumably induced by vasoactive substances (angiotensin, catecholamines) as mirrored by the increase of both plasma renin activity (PRA) and urinary norepinephrine (NE) excretion (+164% and +426%, respectively, vs. control period). AA + D infusion after salt depletion determined a striking rise of both GFR (+30 ml/min, corresponding to 37%) and RPF (+193 ml/min, corresponding to 31%) versus the baseline study of salt depleted condition. The GFR value obtained by AA + D i.v. infusion in the normal condition, however, was not reached presumably because of persistence of extracellular volume contraction, which was confirmed by the persistence of high values of PRA and NE urinary excretion and low values of urinary sodium excretion after AA + D i.v. infusion. GFR impairment due to salt depletion was directly related to the "resting" GFR (P < 0.05) and inversely related to the RFR (P < 0.01): the latter relationship suggests that the greater the "resting" tone of glomerular arterioles (and consequently the value of the RFR), the more minor the role of renal vasoconstriction in causing the fall of GFR following salt depletion. Finally, AA + D infusion in the salt depleted condition induced a GFR increase that is inversely related to the GFR value obtained after salt depletion (P < 0.05). This finding suggests that glomerular arteriolar tone influences, also in a salt depletion condition, the response to AA + D infusion: subjects with a lower GFR (with a greater vasoconstriction), in fact, show a greater increase in GFR after the infusion of these vasodilating substances. depletion condition, the response to AA + D infusion: subjects with a lower GFR (with a greater vasoconstriction), in fact, show a greater increase in GFR after the infusion of these vasodilating substances.

Top

References

  1. Bosch JP, Saccaggi A, Lauer A, Ronco C, Belledonne M, Glabman S: Renal functional reserve in humans. Am J Med 75:943–950, 1986
  2. Bosch JP, Lauer A, Glabman S: Short-term protein loading in assessment of patients with renal disease. Am J Med 77:873–879, 1984
  3. Bosch JP, Lew S, Glabman S, Lauer A: Renal hemodynamic changes in humans. Am J Med 81:809–815, 1986 | Article | PubMed | ISI | ChemPort |
  4. Hostetter TH: Human renal response to a meat meal. Am J Physiol 250 (Renal Fluid Electrol Physiol 19):F613–F618, 1986 | PubMed | ISI | ChemPort |
  5. Chan AY, Cheng ML, Keil L, Myers BD: Functional response of healthy and diseased glomeruli to a large protein-rich meal. J Clin Invest 81:245–254, 1988 | PubMed | ISI | ChemPort |
  6. Graf H, Stummvoll HK, Luger A, Prager R: Effect of ami-noacid infusion on glomerular filtration rate. N Engl J Med 308:159–160, 1983
  7. ter Wee PM, Geerlings W, Rosman JB, Sluiter WJ, van der Geest S, Donker AJM: Testing renal reserve filtration capacity with an amino acid solution. Nephron 41:193–199, 1985
  8. Woods LL, Mizelle L, Montani JP, Hall JE: Mechanisms controlling renal hemodynamics and electrolyte excretion during amino acids. Am J Physiol 20:F303–F312, 1986
  9. Beukhof HR, ter Wee PM, Sluiter WJ, Donker AJM: Effect of low-dose dopamine on effective renal plasma flow and glomerular filtration rate in 32 patients with IgA glomerulopathy. Am J Nephrol 5:267–270, 1985
  10. ter Wee PM, Smit AJ, Rosman JB, Sluiter WJ, Donker AJM: Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. Am J Nephrol 6:42–46, 1986
  11. ter Wee PM, Rosman JB, van der Geest S, Sluiter WJ, Donker AJM: Renal hemodynamics during separate and combined infusion of amino acids and dopamine. Kidney Int 29:870–874, 1986 | PubMed | ChemPort |
  12. Amiel C, Blanchet F, Friendlander G, Nitemberg A: Renal functional reserve. Nephrol Dial Transplant 5:763–770, 1990
  13. Zuccalá A, Zucchelli P: Use and misuse of the renal functional reserve concept in clinical nephrology. Nephrol Dial Transplant 6:410–417, 1990
  14. Ruilope LM, Rodicio J, Robles RG, Sancho J, Miranda B, Granges JP, Romero JC: Influence of a low sodium diet on the renal response to amino acid infusion in humans. Kidney Int 31:992–999, 1987
  15. Tucker BJ, Blantz RC: Mechanism of altered glomerular hemodynamics during chronic sodium depletion. Am J Physiol 13:F11–F18, 1983
  16. Tucker BJ, Mundy CA, Blantz RC: Adrenergic and angiotensin II influences on renal vascular tone in chronic sodium depletion. Am J Physiol 252:F811–F817 1987
  17. Tucker BJ, Peterson OW, Munger KA, Bird JE, Mitchell M, Pelayo JC, Blantz RC: Glomerular hemodynamic alterations during renal nerve stimulation in rats on high- and low-salt diets. Am J Physiol 258:F133–F143, 1990
  18. Steiner RW, Tucker BJ, Blantz RC: Glomerular hemodynamics in rats with chronic sodium depletion. Effect of saralasin. J Clin Invest 64:503–512, 1979 | PubMed | ChemPort |
  19. Pullman TN, Alving AS, Deen RJ, Landonne M: The influence of dietary protein intake on specific renal functions in normal man. J Lab Clin Med 44:320–332, 1954
  20. Bergstrom J, Ahlberg M, Alvestrand A: Influence of protein intake on renal hemodynamics and plasma hormone concentrations in normal subjects. Acta Med Scand 217:189–196, 1985
  21. Jones MG, Lee K, Swaminathan R: The effect of dietary protein on glomerular filtration rate in normal subjects. Clin Nephrol 27:71–75, 1987
  22. Viberti G, Bognetti E, Wiseman MJ, Dodds R, Gross JL, Keen H: Effect of protein-restricted diet on renal response to a meat meal in humans. Am J Physiol (Renal, Fluid Electrol Physiol) 22:F388–F393, 1987
  23. Paller MS, Hostetter TH: Dietary protein increases plasma renin and reduces pressor reactivity to angiotensin II. Am J Physiol (Renal, Fluid Electrol Physiol) 20:F34–F39, 1986
  24. Kirkendall WM, Stein JH: Clinical pharmacology of furosemide and ethacrynic acid. Am J Cardiol (abstract) 22:162, 1968
  25. Williamson HE, Bourland WA, Marchand GR, Farley DB, Van Orden DE: Furosemide-induced release of prostaglandin E to increase renal blood flow. Proc Soc Exp Biol Med 150:104–106, 1975
  26. Conte G, Dal Canton A, Fuiano G, Terribile M, Sabbatini M, Balletta M, Stanziale P, Andreucci VE: Mechanism of impaired concentration in chronic primary glomerulonephritis. Kidney Int 27:792–798, 1985 | Article | PubMed | ChemPort |
  27. Sandhu RS, Freed RM: An improved method for the determination of urinary catecholamines. Clin Chem 14:824–825, 1968
  28. Greene SR, Dalton RN, Turner C, Haycock GB, Chantler C: Hyperglycemia with and without glycosuria: Effect on inulin and para-aminohippurate clearance. Kidney Int 32:896–899, 1987
  29. Mc Donald RH, Goldberg LI, Mc Nay JL, Tuttle EP: Effects of dopamine in man: Augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Invest 43:1116–1124, 1964 | PubMed | ISI | ChemPort |
  30. Chapman BJ, Horn NM, Munday KA, Robertson MJ: The actions of dopamine and of sulpiride on regional blood flows in the rat. J Physiol 298:437–452, 1980 | PubMed | ISI | ChemPort |
  31. Andreucci VE, Dal Canton A, Corradi A, Stanziale R, Migone L: Role of the efferent arteriole in glomerular hemodynamics of superficial nephrons. Kidney Int 9:475–480, 1979
  32. Hardaker WT Jr, Wechsler AS: Redistribution of renal intracortical blood flow during dopamine infusion in dogs. Circ Res 33:437–444, 1973
  33. Neiberger RE, Passmore JC: Effects of dopamine on canine intrarenal blood flow distribution during hemorrhage. Kidney Int 16:219–226, 1979
  34. Lindner A, Cutler RE, Goodman WG: Synergism of dopamine plus furosemide in preventing acute renal failure in the dog. Kidney Int 16:158–166, 1979 | PubMed | ChemPort |
  35. Yared A, Kon V, Ichikawa L: Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. J Clin Invest 75:1477–1487, 1985 | PubMed | ISI | ChemPort |
  36. Navar LG, Marsh DJ, Blantz RC, Hall J, Ploth DW, Nasjletti A: Intrinsic control of renal hemodynamics. Fed Proc 41:3022–3029, 1982
  37. Henrich WL, Berl T, McDonald KM, Anderson RJ, Schrier RW: Angiotensin II, renal nerves, and prostaglandins in renal hemodynamics during hemorrhage. Am J Physiol 4:F46–F51, 1978
  38. Hornich H, Beaufils M, Richet G: The effect of exogenous angiotensin on superficial and deep glomeruli in the rat kidney. Kidney Int 2:336–342, 1972
  39. Cronin RE, Mc Cool AL, De Torrente A, Mc Donald KM, Schrier RW: Norepinephrine induced acute renal failure: A reversible ischemic model of acute renal failure. Kidney Int 14:73–76, 1978
  40. Blantz RC, Konnen KS, Tucker BJ: Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest 57:419–434, 1976 | PubMed | ISI | ChemPort |
  41. Slomowitz LA, Hirschberg R, Kopple JD: Captopril augments the renal response to an amino acid infusion in diabetic adults. Am J Physiol 255:F755–F762, 1988 | PubMed | ChemPort |

Extra navigation

.
ADVERTISEMENT